115 related articles for article (PubMed ID: 26938684)
1. Cross-linking versus RAGE: How do high molecular weight advanced glycation products induce cardiac dysfunction?
Deluyker D; Ferferieva V; Noben JP; Swennen Q; Bronckaers A; Lambrichts I; Rigo JM; Bito V
Int J Cardiol; 2016 May; 210():100-8. PubMed ID: 26938684
[TBL] [Abstract][Full Text] [Related]
2. Glycolaldehyde-Derived High-Molecular-Weight Advanced Glycation End-Products Induce Cardiac Dysfunction through Structural and Functional Remodeling of Cardiomyocytes.
Deluyker D; Evens L; Haesen S; Driesen RB; Kuster D; Verboven M; Beliën H; van der Velden J; Lambrichts I; Bito V
Cell Physiol Biochem; 2020 Aug; 54(5):809-824. PubMed ID: 32857934
[TBL] [Abstract][Full Text] [Related]
3. Acute exposure to glycated proteins reduces cardiomyocyte contractile capacity.
Deluyker D; Evens L; Beliën H; Bito V
Exp Physiol; 2019 Jul; 104(7):997-1003. PubMed ID: 30997698
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ).
Chen M; Li H; Wang G; Shen X; Zhao S; Su W
Metabolism; 2016 Apr; 65(4):441-53. PubMed ID: 26975536
[TBL] [Abstract][Full Text] [Related]
5. Profilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in rats.
Yang D; Liu W; Ma L; Wang Y; Ma J; Jiang M; Deng X; Huang F; Yang T; Chen M
Mol Med Rep; 2017 Nov; 16(5):6634-6641. PubMed ID: 28901418
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of dietary advanced glycation end products in rats.
Poulsen MW; Andersen JM; Hedegaard RV; Madsen AN; Krath BN; Monošík R; Bak MJ; Nielsen J; Holst B; Skibsted LH; Larsen LH; Dragsted LO
Br J Nutr; 2016 Feb; 115(4):629-36. PubMed ID: 26824730
[TBL] [Abstract][Full Text] [Related]
7. AGEs-RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure.
Liang B; Zhou Z; Yang Z; Liu J; Zhang L; He J; Li H; Huang Y; Yang Q; Xian S; Wang L
Exp Physiol; 2022 Aug; 107(8):879-891. PubMed ID: 35598104
[TBL] [Abstract][Full Text] [Related]
8. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats.
Umadevi S; Gopi V; Elangovan V
Chem Biol Interact; 2014 Feb; 208():28-36. PubMed ID: 24309158
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
Caspar-Bell G; Dhar I; Prasad K
Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
[TBL] [Abstract][Full Text] [Related]
11. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation endproducts in food and their effects on health.
Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
[TBL] [Abstract][Full Text] [Related]
13. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
14. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Forbes JM; Thorpe SR; Thallas-Bonke V; Pete J; Thomas MC; Deemer ER; Bassal S; El-Osta A; Long DM; Panagiotopoulos S; Jerums G; Osicka TM; Cooper ME
J Am Soc Nephrol; 2005 Aug; 16(8):2363-72. PubMed ID: 15930093
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of sRAGE on fetal development in pregnant rats with gestational diabetes mellitus.
Tang X; Qin Q; Xie X; He P
Cell Biochem Biophys; 2015 Mar; 71(2):549-56. PubMed ID: 25205260
[TBL] [Abstract][Full Text] [Related]
16. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Yamada S; Takeuchi M; Fukami K; Ueda S; Adachi H; Matsui T; Okuda S; Yamagishi S
Metabolism; 2009 Nov; 58(11):1624-8. PubMed ID: 19604520
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells.
Liu Y; Ma Y; Wang R; Xia C; Zhang R; Lian K; Luan R; Sun L; Yang L; Lau WB; Wang H; Tao L
Antioxid Redox Signal; 2011 Oct; 15(7):1769-78. PubMed ID: 21126209
[TBL] [Abstract][Full Text] [Related]
18. Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac pressure overload.
Haesen S; Cöl Ü; Schurgers W; Evens L; Verboven M; Driesen RB; Bronckaers A; Lambrichts I; Deluyker D; Bito V
Sci Rep; 2020 Jul; 10(1):12220. PubMed ID: 32699285
[TBL] [Abstract][Full Text] [Related]
19. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes.
Su XD; Li SS; Tian YQ; Zhang ZY; Zhang GZ; Wang LX
Arch Med Res; 2011 Oct; 42(7):596-601. PubMed ID: 22100610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
